Cleared Special

K063042 - CARDIOMEM CM 3000-12BT (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K063042 · Getemed Medizin- Und Informationstechnik AG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2007
Decision
239d
Days
Class 2
Risk

K063042 is an FDA 510(k) clearance for the CARDIOMEM CM 3000-12BT. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by Getemed Medizin- Und Informationstechnik AG (Great Neck, US). The FDA issued a Cleared decision on May 30, 2007 after a review of 239 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Getemed Medizin- Und Informationstechnik AG devices

Submission Details

510(k) Number K063042 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 2006
Decision Date May 30, 2007
Days to Decision 239 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 125d · This submission: 239d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 58
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K063042.
HeartBeam AIMIGo(TM) System
K231424 · Heartbeam, Inc. · Dec 2024
ASSURE Wearable ECG
K233864 · Kestra Medical Technologies, Inc. · May 2024
Eclipse MINI Model 98900
K212317 · Spacelabs Healthcare, Ltd. · Nov 2022
Biotres
K222017 · Biotricity · Jul 2022
Q Patch
K210758 · Medicalgorithmics S.A. · Jun 2022
Biotres
K211709 · Biotricity · Jan 2022